NDC 0713-0850 – Griseofulvin
Griseofulvin 125 mg/5mL · Suspension · Oral
Product NDC0713-0850
Product details
- Brand name
- Griseofulvin
- Generic name
- Griseofulvin
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA065438
- Marketed since
- November 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tubulin Inhibiting Agent
Active ingredients
- Griseofulvin 125 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0713-0850-04 | 118 mL in 1 BOTTLE, PLASTIC (0713-0850-04) | Nov 1, 2022 |
Other Griseofulvin products
- 0472-0013 Griseofulvin 125 mg/5mL · Suspension · Actavis Pharma, Inc.
- 62135-968 Griseofulvin 125 mg/5mL · Suspension · Chartwell RX, LLC.
- 0781-5514 Griseofulvin 250 mg/1 · Tablet · Sandoz Inc
- 0781-5515 Griseofulvin 500 mg/1 · Tablet · Sandoz Inc
- 42794-012 Griseofulvin 500 mg/1 · Tablet · Sigmapharm Laboratories, LLC